Fidelity Investments’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.3K Sell
48,700
-53,750
-52% -$107K ﹤0.01% 3993
2025
Q4
$251K Buy
102,450
+20,663
+25% +$89.7K ﹤0.01% 3332
2025
Q3
$549K Buy
81,787
+9,860
+14% +$64.4K ﹤0.01% 2998
2025
Q2
$423K Buy
71,927
+3,676
+5% +$23.9K ﹤0.01% 3022
2025
Q1
$573K Sell
68,251
-2,900
-4% -$26.1K ﹤0.01% 2857
2024
Q4
$529K Sell
71,151
-6,984
-9% -$46.7K ﹤0.01% 2905
2024
Q3
$453K Buy
78,135
+54,353
+229% +$349K ﹤0.01% 2900
2024
Q2
$158K Buy
23,782
+21,446
+918% +$173K ﹤0.01% 3117
2024
Q1
$30.5K Buy
2,336
+654
+39% +$8.72K ﹤0.01% 3822
2023
Q4
$21.4K Buy
1,682
+398
+31% +$4.02K ﹤0.01% 3911
2023
Q3
$16.8K Buy
1,284
+521
+68% +$9.54K ﹤0.01% 3895
2023
Q2
$19.5K Buy
763
+10
+1% +$258 ﹤0.01% 3871
2023
Q1
$19K Buy
753
+171
+29% +$4.01K ﹤0.01% 3860
2022
Q4
$13.4K Sell
582
-392
-40% -$9.03K ﹤0.01% 3913
2022
Q3
$22K Buy
974
+174
+22% +$3.37K ﹤0.01% 3814
2022
Q2
$12K Sell
800
-411,811
-100% -$6.94M ﹤0.01% 4069
2022
Q1
$7.8M Sell
412,611
-183,089
-31% -$3.56M ﹤0.01% 2219
2021
Q4
$11.1M Sell
595,700
-12,965
-2% -$268K ﹤0.01% 2073
2021
Q3
$16.4M Sell
608,665
-6,835
-1% -$188K ﹤0.01% 1934
2021
Q2
$19.2M Buy
+615,500
New +$19.6M ﹤0.01% 1860

Other funds holding TMCI

Fidelity Investments's TMCI Position: Q1 2026 in Review

Fidelity Investments reduced its Treace Medical Concepts (TMCI) stake by 52% in Q1 2026, selling an estimated $107K and leaving 48,700 shares worth $65.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3993.

Fidelity Investments first reported a position in TMCI in Q2 2021 and has held it in 20 quarters since. The position peaked at $19.2M in Q2 2021. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Fidelity Investments held 48,700 shares of Treace Medical Concepts worth $65.3K as of Q1 2026.
  • Fidelity Investments sold 53,750 Treace Medical Concepts shares in Q1 2026, an estimated $107K.
  • Treace Medical Concepts made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3993 holding.
  • Fidelity Investments first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 20 quarters since.
  • Fidelity Investments's Treace Medical Concepts position peaked at $19.2M in Q2 2021.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.